JSPRW icon

Jasper Therapeutics (JSPRW)

NASDAQ

$0.011

-$0.0046 (

-30.46%

)

1D
5D
1M
6M
1Y
5Y
Pre market

JSPRW: $0.011 / ₿ 0 BTC / 14 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$0.015
$0.010 - $0.18
$1.00
$0.011 - $0.016
No

What is Jasper Therapeutics (JSPRW)?

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

The Jasper Therapeutics (JSPRW) stock price has been falling

The Japer Therapeutics, Inc. Warrants (JSPRW) stock pre-market price today is $0.011, reflecting a -30.46% pre-market move since the market last closed. The company’s market capitalization stands at , with a daily trading volume of $1.00 shares. The previous closing price was $0.015.

Get started with Jasper Therapeutics (JSPRW)

Ready to get started? Follow the steps below, or read our guide on how to buy Jasper Therapeutics stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy JSPRW

Search for JSPRW in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy JSPRW.

JSPRW FAQs

JSPRW is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

JSPRW is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Japer Therapeutics, Inc. Warrants (JSPRW) has traded between a low of $0.010 and a high of $0.18.

JSPRW is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Jasper Therapeutics? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
JSPRW icon
JSPRW

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

GOVX icon
NXXT icon

NXXT

MLECW icon

Top losers

Compare the worst-performing stocks of 
the day

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.